Bartelink H - Search Results

1

Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial.

Poortmans PM, Weltens C, Fortpied C, Kirkove C, Peignaux-Casasnovas K, Budach V, van der Leij F, Vonk E, Weidner N, Rivera S, van Tienhoven G, Fourquet A, Noel G, Valli M, Guckenberger M, Koiter E, Racadot S, Abdah-Bortnyak R, Van Limbergen EF, Engelen A, De Brouwer P, Struikmans H, Bartelink H; European Organisation for Research and Treatment of Cancer Radiation Oncology and Breast Cancer Groups. Poortmans PM, et al. Among authors: bartelink h. Lancet Oncol. 2020 Dec;21(12):1602-1610. doi: 10.1016/S1470-2045(20)30472-1. Epub 2020 Nov 2. Lancet Oncol. 2020. PMID: 33152277 Clinical Trial.

2

Primary radiotherapy of breast cancer: treatment results in locally advanced breast cancer and in operable patients selected by positive axillary apex biopsy.

Borger JH, van Tienhoven G, Passchier DH, Hart AA, van Dongen JA, Rutgers EJ, Bartelink H. Borger JH, et al. Among authors: bartelink h. Radiother Oncol. 1992 Sep;25(1):1-11. doi: 10.1016/0167-8140(92)90188-z. Radiother Oncol. 1992. PMID: 1410583

3

Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer.

van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Tong D, Winter J, et al. van Dongen JA, et al. Among authors: bartelink h. Eur J Cancer. 1992;28A(4-5):801-5. doi: 10.1016/0959-8049(92)90118-l. Eur J Cancer. 1992. PMID: 1524898 Clinical Trial.

4

Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial.

van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, van der Schueren E, Sylvester R, Winter J, van Zijl K. van Dongen JA, et al. Among authors: bartelink h. J Natl Cancer Inst Monogr. 1992;(11):15-8. J Natl Cancer Inst Monogr. 1992. PMID: 1627421 Clinical Trial.

5

Quality assurance of the EORTC trial 22881/10882: "assessment of the role of the booster dose in breast conserving therapy": the Dummy Run. EORTC Radiotherapy Cooperative Group.

van Tienhoven G, van Bree NA, Mijnheer BJ, Bartelink H. van Tienhoven G, et al. Among authors: bartelink h. Radiother Oncol. 1991 Dec;22(4):290-8. doi: 10.1016/0167-8140(91)90165-d. Radiother Oncol. 1991. PMID: 1792323 Review.

6

Quality assurance in conservative treatment of early breast cancer. Report on a consensus meeting of the EORTC Radiotherapy and Breast Cancer Cooperative Groups and the EUSOMA (European Society of Mastology).

Bartelink H, Garavaglia G, Johansson KA, Mijnheer BJ, Van den Bogaert W, van Tienhoven G, Yarnold J. Bartelink H, et al. Radiother Oncol. 1991 Dec;22(4):323-6. doi: 10.1016/0167-8140(91)90172-d. Radiother Oncol. 1991. PMID: 1792330 Review.

7

Results of radiotherapy in patients with stage I orbital non-Hodgkin's lymphoma.

Letschert JG, González González D, Oskam J, Koornneef L, van Dijk JD, Boukes R, Bras J, van Heerde P, Bartelink H. Letschert JG, et al. Among authors: bartelink h. Radiother Oncol. 1991 Sep;22(1):36-44. doi: 10.1016/0167-8140(91)90067-q. Radiother Oncol. 1991. PMID: 1947211 Review.

8

Radiotherapy in the management of early breast cancer: a review.

Bartelink H. Bartelink H. Eur J Cancer Clin Oncol. 1988 Jan;24(1):77-82. doi: 10.1016/0277-5379(88)90180-0. Eur J Cancer Clin Oncol. 1988. PMID: 3276536 Review.

9

Evaluation of breast conserving therapy: clinical, methodological and psychosocial perspectives.

Aaronson NK, Bartelink H, van Dongen JA, van Dam FS. Aaronson NK, et al. Among authors: bartelink h. Eur J Surg Oncol. 1988 Apr;14(2):133-40. Eur J Surg Oncol. 1988. PMID: 3360154

10

Patient population analysis in EORTC trial 22881/10882 on the role of a booster dose in breast-conserving therapy.

Ptaszynski A, Van den Bogaert W, Van Glabbeke M, Pierart M, Bartelink H, Horiot JC, Fourquet A, Struikmans H, Hamers H, Müller RP, et al. Ptaszynski A, et al. Among authors: bartelink h. Eur J Cancer. 1994;30A(14):2073-81. doi: 10.1016/0959-8049(94)00310-2. Eur J Cancer. 1994. PMID: 7857706 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

319 results

Search Page